Reuters logo
BRIEF-Ose Immunotherapeutics FY net profit rises to 20.7 million euros
March 28, 2017 / 4:57 PM / 6 months ago

BRIEF-Ose Immunotherapeutics FY net profit rises to 20.7 million euros

March 28 (Reuters) - Ose Immunotherapeutics SA:

* FY net profit of 20.7 million euros ($22.4 million) versus loss of 5.6 million euros year ago

* FY revenue 383 ,000 euros versus 4,000 euros year ago

* Cash position at Dec. 31, 17.8 million euros versus 15.1 million euros year ago

* FY operating profit of 17.5 million euros versus loss of 5.4 million euros year ago

* 2017 outlook in auto-immune diseases: to pursue the product’s clinical development through partnerships

* Says it has funds for operations until the second half of 2018 Source text for Eikon: Further company coverage: ($1 = 0.9225 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below